The Effects of Dexmedetomidine Or Remifentanyl Continuous Infusion on End-Tidal Sevoflurane Concentration In patients undergoing Laparoscopic Cholecestectomies, Monitored by Bispectral Analysis
Not Applicable
- Conditions
- Surgerylaparoscopic cholecystectomies
- Registration Number
- PACTR201611001829308
- Lead Sponsor
- Tanta Univercity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
ASA I-II patients scheduled for elective Videolaparoscopic cholecystectomy were included
Exclusion Criteria
). Patients were excluded if they had severe cardiac disease, chronic obstructive lung disease, renal and hepatic insufficiency, endocrine, metabolic or central nervous system disorders, a-2-agonist or antagonist therapy taken, and active upper respiratory infection, those receiving medications known to affect MAC, or having a history of alcohol or drug abuse; and women who were lactating or pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method End-tidal CO2 (ETCO2) concentration and end-expiratory concentration of sevoflurane
- Secondary Outcome Measures
Name Time Method hemodynamic parameters and BIS during laparoscopic cholecystectomies